An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you're connecting to the official website and that any information you provide is encrypted and sent securely.
If you are a Veteran in crisis or concerned about one, connect with our caring, qualified responders for confidential help. Many of them are Veterans themselves.
Jones BE, Ying J, Nevers M, Rutter ED, Chapman AB, Brenner R, Samore MH, Greene T. Hospital admission decisions for older Veterans with community-onset pneumonia: An analysis of 118 U.S. Veterans Affairs Medical Centers. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Apr 1; 30(4):398-409.
Shore S, O'Leary M, Kamdar N, Harrod M, Silveira MJ, Hummel SL, Nallamothu BK. Do Not Attempt Resuscitation Order Rates in Hospitalized Patients With Heart Failure, Acute Myocardial Infarction, Chronic Obstructive Pulmonary Disease, and Pneumonia. Journal of the American Heart Association. 2022 Dec 6; 11(23):e025730.
Teno JM, Sullivan DR, Bunker J, Gozalo P. Survival and Healthcare Costs with Invasive Mechanical Ventilation versus Noninvasive Ventilation in Patients with Dementia Admitted with Pneumonia and Respiratory Failure. Annals of the American Thoracic Society. 2022 Aug 1; 19(8):1364-1370.
Silva GC, Jiang L, Gutman R, Wu WC, Mor V, Fine MJ, Kressin NR, Trivedi AN. Racial/Ethnic Differences in 30-Day Mortality for Heart Failure and Pneumonia in the Veterans Health Administration Using Claims-based, Clinical, and Social Risk-adjustment Variables. Medical care. 2021 Dec 1; 59(12):1082-1089.
Khan N, Patel D, Trivedi C, Pernes T, Kavani H, Xie D, Yang YX. The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients. Alimentary pharmacology & therapeutics. 2022 Jan 1; 55(1):64-72.
Carey E, Blankenhorn R, Chen P, Munro S. Non-ventilator associated hospital acquired pneumonia incidence and health outcomes among U.S. veterans from 2016-2020. American journal of infection control. 2022 Jan 1; 50(1):116-119.
Nair R, Gao Y, Vaughan-Sarrazin MS, Perencevich E, Girotra S, Pandey A. Risk-Standardized Home Time as a Novel Hospital Performance Metric for Pneumonia Hospitalization Among Medicare Beneficiaries: a Retrospective Cohort Study. Journal of general internal medicine. 2021 Oct 1; 36(10):3031-3039.
Jones BE, Jones MM. Pneumonia and Electronic Health Records-A Window Into Disease, A Mirror of Our Behavior, or Just Another Streetlight? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Oct 23; 71(7):1613-1615.
Bostwick AD, Jones BE, Paine R, Goetz MB, Samore M, Jones M. Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics. An Evaluation of 113 Veterans Affairs Medical Centers. Annals of the American Thoracic Society. 2019 Nov 1; 16(11):1392-1398.
Munro SM, Baker D. Integrating Oral Health Care into Patient Management to Prevent Hospital-Acquired Pneumonia: A Team Approach. Michigan Dental Association. 2019 Jul 1; 7(1):48-57.
Zifodya JS, Crothers K. Treating bacterial pneumonia in people living with HIV. Expert review of respiratory medicine. 2019 Aug 1; 13(8):771-786.
Munro S, Haile-Mariam A, Greenwell C, Demirci S, Farooqi O, Vasudeva S. Implementation and Dissemination of a Department of Veterans Affairs Oral Care Initiative to Prevent Hospital-Acquired Pneumonia Among Nonventilated Patients. Nursing Administration Quarterly. 2018 Oct 1; 42(4):363-372.
Munro S, Baker D. Reducing missed oral care opportunities to prevent non-ventilator associated hospital acquired pneumonia at the Department of Veterans Affairs. Applied nursing research : ANR. 2018 Dec 1; 44:48-53.
Royer S, Prescott HC. Next Steps for Confirming Bronchoalveolar Lavage Amlyase as an Useful Biomarker for Ventilator-Associated Pneumonia. [Editorial]. Critical care medicine. 2018 Jan 1; 46(1):165-166.
Sutton JD, Graber CJ, Goetz MB, Madaras-Kelly K, Jones M, Glassman PA, Spivak E. Visual analytic tools for automated measurement and tracking of durations of therapy for pneumonia, urinary tract infections, and skin and soft tissue infections. [Abstract]. Open forum infectious diseases. 2017 Oct 4; 4(Supplemental 1):S511-S512.
Angarita SAK, Russell TA, Kaldas FM. Pneumonia after liver transplantation. Current opinion in organ transplantation. 2017 Aug 1; 22(4):328-335.
Batais MA, Khan AR, Bin Abdulhak AA. The Use of Statins and Risk of Community-Acquired Pneumonia. Current Infectious Disease Reports. 2017 Aug 1; 19(8):26.
Lee JS, Giesler DL, Fine MJ. Duration of Antibiotic Therapy for Community-Acquired Pneumonia in the Era of Personalized Medicine. JAMA : the journal of the American Medical Association. 2016 Dec 20; 316(23):2544-2545.
Lee JS, Giesler DL, Fine MJ. Management of Community-Acquired Pneumonia--Reply. [Letter to the Editor]. JAMA : the journal of the American Medical Association. 2016 Jul 12; 316(2):222-3.
Iwashyna T. Increasing ICU Access Can Improve Outcomes for Pneumonia. Paper presented at: Intensive Care and Emergency Medicine International Symposium; 2016 Mar 16; Brussels, Belgium.
Lee JS, Giesler DL, Gellad WF, Fine MJ. Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review. JAMA. 2016 Feb 9; 315(6):593-602.
Mortensen EM, Bollinger M, Fine MJ. Electronic medical record based intervention to reduce length of stay for Veterans hospitalized with pneumonia. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
McDanel J, Goto M, Jones M, Franciscus CL, Alexander B, Richardson KK, Perencevich EN. Eleven Year Trends in Antimicrobial Non-Susceptibility among Klebsiella pneumoniae Isolates in the Veterans Health Administration. Poster session presented at: Society for Healthcare Epidemiology of America Annual Scientific Meeting; 2015 May 15; Orlando, FL.
Corrales-Medina VF, Alvarez KN, Yende S. Hospitalization for pneumonia and risk of cardiovascular disease--reply. JAMA : the journal of the American Medical Association. 2015 May 5; 313(17):1753-4.
Sjoding MW, Iwashyna TJ, Dimick JB, Cooke CR. Gaming hospital-level pneumonia 30-day mortality and readmission measures by legitimate changes to diagnostic coding. Critical care medicine. 2015 May 1; 43(5):989-95.
Davydow DS, Hough CL, Zivin K, Langa KM, Katon WJ. Depression and risk of hospitalization for pneumonia in a cohort study of older Americans. Journal of psychosomatic research. 2014 Dec 1; 77(6):528-34.
Lee JS, Fine MJ. The debate on antibiotic therapy for patients hospitalized for pneumonia: where should we go from here? JAMA internal medicine. 2014 Dec 1; 174(12):1901-3.
Prescott HC, Sjoding MW, Iwashyna TJ. Diagnoses of early and late readmissions after hospitalization for pneumonia. A systematic review. Annals of the American Thoracic Society. 2014 Sep 1; 11(7):1091-100.
Mortensen E, Halm E, Fine MJ, Johnson C, Anuzeto A. Azithromycin is associated with increased cardiac events but lower mortality for older patients hospitalized with pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 24; San Diego, CA.
Flanders SA, Saint S. Measuring pneumonia-related mortality using administrative data: coding and consequences. Annals of internal medicine. 2014 Mar 18; 160(6):430-1.
Jones B, Gundlapalli AV, Jones JP, Brown SM, Dean NC. Admission decisions and outcomes of community-acquired pneumonia in the homeless population: a review of 172 patients in an urban setting. American journal of public health. 2013 Dec 1; 103 Suppl 2:S289-93.
Justice AC. Comparing clinical outcomes of HIV-infected to HIV-uninfected older adults hospitalized with community-acquired pneumonia. Poster session presented at: Infectious Diseases Society of America Annual Meeting; 2013 Oct 2; San Francisco, CA.
Huttner B, Jones M, Huttner A, Rubin M, Samore MH. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system. The Journal of antimicrobial chemotherapy. 2013 Oct 1; 68(10):2393-9.
Rosen AK, Chen Qi, O'Brien W, Borzecki AM, Frakt AB, Shwartz M, Bauer MS. Assessing the Impact of Serious Mental Illness (SMI) and Substance Use Disorders (SUD) on Risk of Readmission for Patients with Acute Myocardial Infarction, Heart Failure, and Pneumonia in the Veterans Health Administration (VA). Presented at: AcademyHealth Annual Research Meeting; 2013 Jun 25; Baltimore, MD.
Chen Q, Borzecki A, O'Brien W, Mull HJ, Restuccia J, Rosen AK. Validating the 3M™ Potentially Preventable Readmissions Software in a Cohort of Veterans with Pneumonia. Poster session presented at: AcademyHealth Annual Research Meeting; 2013 Jun 24; Baltimore, MD.
Fine MJ, Mortensen EM, Halm E, Anzueto A. Azithromycin is associated with increased cardiac events but lower mortality for patients hospitalized with pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 19; Philadelphia, PA.
Metersky ML, Fine MJ, Mortensen EM. The effect of marital status on the presentation and outcomes of elderly male veterans hospitalized for pneumonia. Chest. 2012 Oct 1; 142(4):982-987.
Wilson BZ, Anzueto A, Restrepo MI, Pugh MJ, Mortensen EM. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia. Critical care medicine. 2012 Aug 1; 40(8):2310-4.
Fernandez JF, Levine SM, Restrepo MI. Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia. Chest. 2012 Jul 1; 142(1):231-8.
Fernandez JF, Sibila O, Restrepo MI. Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers. Expert review of clinical pharmacology. 2012 Jul 1; 5(4):445-58.
Janus TJ, Vaughan-Sarrazin MS, Baker LJ, Smith HL. Predictors of pneumonia in trauma patients with pulmonary contusion. Journal of trauma nursing : the official journal of the Society of Trauma Nurses. 2012 Jul 1; 19(3):139-47.
Restrepo MI, Anzueto A. Global trends in community-acquired pneumonia. Introduction. Seminars in respiratory and critical care medicine. 2012 Jun 20; 33(3):211-2.
Restrepo MI. Process Improvement: Impact on Outcomes of Patients with Pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 21; San Francisco, CA.
Kollef M, Restrepo MI, Jolson H, Clavel M, Michiels B, Kaniga K, Cirillo I, Redman R. A phase 3, double-blind, double-dummy study assessing the safety and efficacy of a short course of doripenem 1 Gram in the treatment of subjects with ventilator-associated pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
Sibila O, Mortensen EM, Anzueto A, Laserna E, Restrepo MI. Prior cardiovascular disease is associated with increased short and long-term mortality in COPD patients with community-acquired pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
Restrepo MI. Community-acquired pneumonia. Update. Paper presented at: Pneumology and Thoracic Surgery National Congress (Congreso Nacional de Neumología y Cirugía de Tórax); 2012 Apr 13; Cancun, Mexico.
Rodriguez-Barradas M. Methodology to identify and validate community-acquired pneumonia using administrative data compared to web-based adjudication. Poster session presented at: International Workshop on HIV Observational Databases; 2012 Mar 29; Athens, Greece.
Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL. Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia. Journal of hospital medicine. 2012 Mar 1; 7(3):195-202.
Renaud B, Brun-Buisson C, Santin A, Coma E, Noyez C, Fine MJ, Yealy DM, Labarère J. Outcomes of early, late, and no admission to the intensive care unit for patients hospitalized with community-acquired pneumonia. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2012 Mar 1; 19(3):294-303.
Marcos PJ, Restrepo MI, Verea H. Community acquired pneumonia: severity scores as an adjunct to clinical judgement. European Respiratory Journal. 2012 Feb 1; 39(2):509.
Restrepo MI. Combination Therapy for Severe Community Acquired Pneumonia. Paper presented at: Pan-American and Iberian Congress of Intensive Care Medicine; 2011 Dec 3; Cartagena, Columbia.
Restrepo MI, Mortensen EM, Anzueto A. Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? European Respiratory Journal. 2011 Jul 1; 38(1):1-3.
Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2011 Jun 1; 15(6):e382-7.
Mortensen EM. Potential causes of increased long-term mortality after pneumonia. [Editorial]. European Respiratory Journal. 2011 Jun 1; 37(6):1306-7.
Fine MJ. The pneumonia severity index: from derivation to implementation. Presented at: Swiss Society for Internal Medicine Annual Meeting; 2011 May 13; Lausanne, Switzerland.
Hanks D. HSR&D Stories-d, Improving Influenza and Pneumonia Vaccination among Veterans. 2011 May 10; 1(4).
Lee JS, Primack BA, Mor MK, Stone RA, Obrosky DS, Yealy DM, Fine MJ. Does performance of evidence-based processes of care improve survival for patients with community-acquired pneumonia? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2011 May 4; Phoenix, AZ.
Walkey AJ, O'Donnell MR, Wiener RS. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials. Chest. 2011 May 1; 139(5):1148-55.
Hsu JL, Siroka AM, Smith MW, Holodniy UG, Meduri UG. One-Year Outcomes of Community-Acquired and Health Care-Associated Pneumonia in the Veterans Affairs Health Care System. Poster session presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 2010 Sep 12; San Francisco, CA.
Chang A, Walter LC. Recognizing dementia as a terminal illness in nursing home residents: Comment on "Survival and comfort after treatment of pneumonia in advanced dementia". Archives of internal medicine. 2010 Jul 12; 170(13):1107-9.
Cecere LM, Sun H, Bryson CL, Bradley KA, Williams E, Au DH. The Association between Smoking Cessation and Risk of Hospitalization for Pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2010 May 15; New Orleans, LA.
Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Archives of internal medicine. 2010 Feb 22; 170(4):347-53.
Joo MJ, Au DH, Fitzgibbon ML, Lee TA. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respiratory medicine. 2010 Feb 1; 104(2):246-52.
South B, Gundlapalli A, Kim B, DuVall SL, Samore MH, Delisle S. Automated Classification of Pneumonia Cases using Chest X-Ray Reports for Hospital and Public Health Surveillance. Poster session presented at: International Society for Disease Surveillance Annual Conference; 2009 Dec 3; Miami, FL.
South B, Gundlapalli A, Kim B, DuVall SL, Samore MH, Delisle S. Identifying Pneumonia Cases using Chest X-Ray Reports for Hospital and Public Health Surveillance. Paper presented at: International Society for Disease Surveillance Annual Conference; 2009 Dec 3; Miami, FL.
Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ. Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Nov 15; 49(10):e100-8.
Madaras K, Remington RE, Fan VS, Sloan KL. How Often is a Microbial Etiology Identified in Health Care-Associated Pneumonia (HCAP)? Poster session presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 2009 Sep 13; San Francisco, CA.
Malo de Molina R, Mortensen EM, Restrepo MI, Copeland LA, Pugh MV, Anzueto A. Outpatient Inhaled Corticosteroid (ICS) therapy decreases mortality in patients with Chronic Obstructive Pulmonary Disease (COPD) and pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2009 May 15; San Diego, CA.
Hutt EA, Corbett KK, Bent K, Ruscin JM, Williams EM. Challenges to Implementing Guidelines for Treating Nursing Home-Acquired Pneumonia: A Qualitative Assessment of Variation in Five Settings. Presented at: VA QUERI National Meeting; 2008 Dec 10; Phoenix, AZ.
Aujesky D, Fine MJ. Community-acquired pneumonia: treatment at home or in the hospital? The American journal of medicine. 2008 Dec 1; 121(12):1038-40.
Aujesky D, Fine MJ. The pneumonia severity index: a decade after the initial derivation and validation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Dec 1; 47 Suppl 3:S133-9.
Mortensen EM, Restrepo MI, Copeland LA, Pugh JA, Anzueto A. Association of hydrophilic versus lipophilic angiotensin-converting enzyme inhibitor use on pneumonia-related mortality. The American journal of the medical sciences. 2008 Dec 1; 336(6):462-6.
Mortensen EM, Restrepo MI, Pugh JA, Anzueto A. Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study. BMC Res Notes. 2008 Dec 1; 1:120.
Malo de Molina R, Mortensen EM, Castellanos-Matteus P, Anzueto A, Restrepo MI. The impact of outpatient inhaled corticosteroid therapy on disease severity in hospitalized patients with community acquired pneumonia. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2008 Oct 25; Philadelphia, PA.
Malo de Molina R, Mortensen EM, Restrepo MI, Castellanos-Matteus P, Anzueto A. Impact of pulmonary arterial hypertension (PAH) in patients hospitalized with community acquired pneumonia (CAP) or sepsis. Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2008 Oct 25; Philadelphia, PA.
Hutt E, Radcliff TA, Liebrecht D, Fish R, McNulty M, Kramer AM. Associations among nurse and certified nursing assistant hours per resident per day and adherence to guidelines for treating nursing home-acquired pneumonia. The journals of gerontology. Series A, Biological sciences and medical sciences. 2008 Oct 1; 63(10):1105-11.
Krein SL, Kowalski CP, Damschroder L, Forman J, Kaufman SR, Saint S. Preventing ventilator-associated pneumonia in the United States: a multicenter mixed-methods study. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2008 Oct 1; 29(10):933-40.
Tobia CC, Aspinall SL, Good CB, Fine MJ, Hanlon JT. Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clinical therapeutics. 2008 Jun 1; 30(6):1135-44.
Mortensen EM, Restrepo MI, Pugh JA, Anzueto AR. Impact of prior outpatient antibiotic use on mortality for patients hospitalized with community-acquired pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 16; Toronto, Canada.
Sanchez JF, Mortensen EM, Anzueto A, Restrepo MI. Validation of the minor ATS/IDSA criteria on mortality and ICU admission in patients with severe pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 16; Toronto, Canada.
Mortensen EM, Restrepo MI, Anzueto A. When to switch therapy in patients with severe community-acquired pneumonia. [Letter to the Editor]. Annals of internal medicine. 2008 Apr 15; 148(8):625; author reply 625-6.
Krein SL, Kowalski, Kaufman, Forman, Damschroder, Saint. Preventing Ventilator-Associated Pneumonia in U.S. Hospitals: A Mixed Methods Study. Paper presented at: Society for Healthcare Epidemiology of America Scientific Annual Meeting; 2008 Apr 7; Orlando, FL.
Mortensen EM, Restrepo MI, Copeland LA, Anzueto AR, Pugh MJ. Association of lipophilic and hydrophilic ACE inhibitor use with pneumonia-related mortality. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 1; Pittsburgh, PA.
Mortensen EM, Restrepo MI, Pugh JA, Anzueto AR. Impact of prior outpatient antibiotic use on mortality for patients hospitalized for community-acquired pneumonia. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 1; Pittsburgh, PA.
Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Feb 15; 46(4):550-6.
Fine MJ. The Pneumonia Severity Index: a decade after development. Paper presented at: Infectious Diseases Society of America / Federal Drug Administration Community-Acquired Pneumonia Annual Workshop; 2008 Jan 17; Silver Spring, MD.
Gould CV, Sniegowski PD, Shchepetov M, Metlay JP, Weiser JN. Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis. Antimicrobial agents and chemotherapy. 2007 Sep 1; 51(9):3225-9.
Pines JM, Hollander JE, Lee H, Everett WW, Uscher-Pines L, Metlay JP. Emergency department operational changes in response to pay-for-performance and antibiotic timing in pneumonia. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2007 Jun 1; 14(6):545-8.
Yealy DM, Auble TE, Fine MJ. Using the pneumonia severity index to guide hospitalization decisions. The American journal of medicine. 2007 Jun 1; 120(6):e21.
Hutt E, Radcliff T, Liebrecht D, Fish R, McNulty M, Kramer A. Nursing Home-Acquired Pneumonia Treatment Guideline Adherence is Associated with Nurse Staffing Ratios and Turnover. Paper presented at: American Geriatrics Society Annual Meeting; 2007 May 2; Seattle, WA.
Mortensen EM, Restrepo M, Copeland LA, Anzueto AR, Pugh JA. Association of lipophilic and hydrophilic ACE inhibitors with pneumonia-related mortality. Presented at: American Thoracic Society Annual International Conference; 2007 May 1; San Francisco, CA.
Lee TA, Weaver FM, Weiss KB. Impact of Pneumococcal Vaccination on Pneumonia Rates in Patients with COPD and Asthma. Journal of general internal medicine. 2007 Jan 1; 22(1):62-7.
Restrepo MI, Anzueto A. The role of new therapies for severe community-acquired pneumonia. Current opinion in infectious diseases. 2006 Dec 1; 19(6):557-64.
Mortensen. Impact of statins in patients with pneumonia and sepsis. Presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2006 Oct 21; Salt Lake City, UT.
Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. The American journal of medicine. 2006 Oct 1; 119(10):865-71.
Hutt E. Improving Care for Nursing Home Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Mountain West Regional Annual Meeting; 2006 Sep 1; Aspen, CO.
Pines JM, Hollander JE, Localio AR, Metlay JP. The association between emergency department crowding and hospital performance on antibiotic timing for pneumonia and percutaneous intervention for myocardial infarction. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2006 Aug 1; 13(8):873-8.
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. European Respiratory Journal. 2006 Aug 1; 28(2):346-51.
Hutt E, Rumsfeld JS, Kramer AM, Williams EM, Liebrecht D, Klenke W, Hartmann S. A Multifaceted Intervention to Implement Guidelines Improved Treatment of Nursing Home-Acquired Pneumonia in a State Veterans Home. Paper presented at: Agency for Healthcare Research and Quality Translating Research Into Practice and Policy Annual Meeting; 2006 Jul 1; Washington, DC.
Fine MJ. Ensuring timely administration of antibiotic therapy for patients with community-acquired pneumonia in the VA Healthcare System [plenary talk]. Paper presented at: VA Optimizing Clinical Performance Through Systems Management Conference; 2006 Jun 6; Phoenix, AZ.
Aspinall SL, Hyman KB, Fine MJ. Ensuring timely administration of antibiotic therapy for patients with community-acquired pneumonia. Paper presented at: VA VISN Formulary Leaders Meeting; 2006 May 17; Chicago, IL.
Barnett MJ, Perry PJ, Alexander B, Kaboli PJ. Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients. Journal of Clinical Psychopharmacology. 2006 Apr 1; 26(2):182-7.
Obrosky DS, Edick SM, Fine MJ. The emergency department triage of community-acquired pneumonia project data and documentation systems: a model for multicenter clinical trials. IEEE Transactions On Information Technology in Biomedicine : A Publication of The Ieee Engineering in Medicine and Biology Society. 2006 Apr 1; 10(2):377-84.
Flanders SA, Collard HR, Saint S. Nosocomial pneumonia: state of the science. American journal of infection control. 2006 Mar 1; 34(2):84-93.
Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum. 2006 Feb 1; 54(2):628-34.
Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine. 2006 Jan 23; 24(4):468-75.
Anzueto A, Niederman MS, Pearle J, Restrepo MI, Heyder A, Choudhri SH. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Jan 1; 42(1):73-81.
Velez JA, Mortensen EM, Anzueto A, Restrepo MI. Analisis de severidad y criterios de hospitalizacion en pacientes con neumonia adquirida en la comunidad [Severity of illness analysis and hospitalization criteria for patients with community-acquired pneumonia]. Revista CES Medicina. 2006 Jan 1; 20(1):15-23.
Frei C, Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Validation of guideline-concordant empiric antibiotic therapy for ICU patients with community-acquired pneumonia. Paper presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy / Infectious Diseases Society of America Joint Meeting; 2005 Dec 16; Washington, DC.
Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The impact of empiric antimicrobial therapy with a ß-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Critical Care (London, England). 2005 Dec 6; 10(1):R8.
Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Impact of guideline-concordant antibiotic therapy on mortality within 48 hours of admission for patients hospitalized with community-acquired pneumonia / Chest. Paper presented at: American College of Surgeons Spring Meeting; 2005 Oct 31; Montréal, Canada.
Frei C, Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Impact of guideline concordant empiric antibiotic therapy in hospitalized patients with community-acquired pneumonia. Paper presented at: Infectious Diseases Society of America Annual Meeting; 2005 Oct 6; San Francisco, CA.
Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 Oct 1; 41(7):923-9.
Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Critical care medicine. 2005 Oct 1; 33(10):2184-93.
Aujesky D, Fine MJ. Does guideline adherence for empiric antibiotic therapy reduce mortality in community-acquired pneumonia [editorial]. [Editorial]. American journal of respiratory and critical care medicine. 2005 Sep 15; 172(6):655-656.
Restrepo MI, Angel LF, Mortensen EM, Anzueto A. Steroid infusion for severe pneumonia: not so fast... American journal of respiratory and critical care medicine. 2005 Sep 15; 172(6):781; author reply 782-3.
Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC pulmonary medicine. 2005 Sep 13; 5:12.
Stone RA, Mor MK, Lave JR, Hough LJ, Fine MJ. Implementation of an inpatient management and discharge strategy for patients with community-acquired pneumonia. The American journal of managed care. 2005 Aug 1; 11(8):491-9.
Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respiratory Research. 2005 Jul 25; 6:82.
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Evaluation of predictive tools to define need for ICU in patients with community-acquired pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2005 May 20; San Diego, CA.
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Quality of care in intensive care unit patients with severe community-acquired pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2005 May 20; San Diego, CA.
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. The association between systemic steroid use and mortality in patients hospitalized with community-acquired pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2005 May 20; San Diego, CA.
Lee TA, Xu J, Weaver FM, Weiss KB. Risk of Pneumonia-Related Hospitalizations in Patients with Chronic Lung Disease. Poster session presented at: American Thoracic Society Annual International Conference; 2005 May 1; San Diego, CA.
McCausland JB, Auble TE, Whittle J, Obrosky DS, Yealy DM, Fine MJ. Clinician-reported barriers for admission of low risk and discharge of higher risk patients with pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2005 May 1; New Orleans, LA.
Renaud B, Coma E, Labarere J, Hayon J, Longo C, Blancher M, Fine MJ, Roupe E. Effectiveness and safety of using the pneumonia severity index to triage patients with pneumonia in the emergency department: a multicenter European study. Paper presented at: Society of General Internal Medicine Annual Meeting; 2005 May 1; New Orleans, LA.
Restrepo MI, Anzueto A. Antimicrobial treatment of community-acquired pneumonia. Clinics in Chest Medicine. 2005 Mar 1; 26(1):65-73.
Mortensen EM, Restrepo MI, Anzueto A, Pugh J. Differences in length of stay for patients with community-acquired pneumonia. Poster session presented at: VA HSR&D National Meeting; 2005 Feb 16; Baltimore, MD.
Restrepo M, Mortensen EM, Anzueto A, Pugh J. Evaluation of predictive tools to define need for ICU in patients with community-acquired pneumonia. Paper presented at: VA HSR&D National Meeting; 2005 Feb 16; Baltimore, MD.
Chang HT, Evans CT, Weaver FM, Burns SP, Parada JP. Etiology and outcomes of veterans with spinal cord injury and disorders hospitalized with community-acquired pneumonia. Archives of physical medicine and rehabilitation. 2005 Feb 1; 86(2):262-7.
Lee TA, Xu J, Weaver FM, Weiss KB. Risk of Pneumonia-Related Hospitalizations in Patients with Chronic Lung Disease. Poster session presented at: VA HSR&D National Meeting; 2005 Feb 1; Baltimore, MD.
Metlay JP. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia. Infectious Disease Clinics of North America. 2004 Dec 1; 18(4):777-90.
Mortensen EM, Restrepo M, Anzueto A, Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. The American journal of medicine. 2004 Nov 15; 117(10):726-31.
Klugman KP, Low DE, Metlay J, Pechere JC, Weiss K. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities. International Journal of Antimicrobial Agents. 2004 Nov 1; 24(5):411-422.
Restrepo MI, Mortensen EM, Anzueto A. Community-Acquired Pneumonia (International Version). In: Ortiz-Ruiz G, Perafan MA, Faist E, editors. Sepsis. New York, NY: Springer-Verlag; 2004. Chapter 4. 41-52 p.
Restrepo MI, Mortensen EM, Waratunge N, Pugh JA, Anzueto A. Should All Bacteremic Pneumococcal Pneumonia Patients Be Considered Severe Community-Acquired Pneumonia? Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2004 Oct 27; Seattle, WA.
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. The Association between Statin Use and Mortality for Patients Hospitalized with Community-Acquired Pneumonia. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2004 Oct 26; Seattle, WA.
Mortensen EM, Cornell J, Whittle J. Racial variations in processes of care for patients with community-acquired pneumonia. BMC health services research. 2004 Aug 10; 4(1):20.
McBean AM, Hebert PL. New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2004 Jul 1; 8(4):227-35.
Aujesky DA, Stone RA, Obrosky DS, Yealy DM, Auble TE, Fine MJ. How good is the agreement between prospectively and retrospectively collected data comprising the pneumonia severity index. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 12; Chicago, IL.
McCausland JB, Yealy DM, Fine MJ. The agree instrument: critical appraisal of community-acquired pneumonia guidelines by physicians. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 12; Chicago, IL.
Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. The Association between Statin and ACE Inhibitor Use and Mortality for Patients Hospitalized with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 11; Chicago, IL.
Fine MJ, Auble TE, Stone RA. The Emergency Department Community-Acquired Pneumonia (EDCAP) trial: effectiveness of guideline implementation strategies to improve initial quality of care. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 2; Chicago, IL.
Metlay JP. Risk factors for drug resistant pneumococcal pneumonia. Paper presented at: Pneumococci and Pneumococcal Diseases International Annual Symposium; 2004 May 1; Helsinki, Finland.
Shutt CK, Samore M, Carroll KC. Comparison of the Denka Seiken slide agglutination method to the quellung test for serogrouping of Streptococcus pneumoniae isolates. Journal of clinical microbiology. 2004 Mar 1; 42(3):1274-6.
Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2003 Dec 15; 37(12):1617-24.
Restrepo MI, Mortensen EM, Anzueto A, Pugh JA. Mortality in Monotherapy versus Combination Therapy in Severe Community-Acquired Pneumonia: A Systematic Review. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2003 Oct 29; Orlando, FL.
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Is Combination Therapy Needed in Hospitalized Patients with Community-Acquired Pneumonia? Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2003 Oct 29; Orlando, FL.
Chang HT, Evans CT, Weaver FM, Burns SP, Parada JP. Etiology and outcomes of Veterans with spinal cord injury hospitalized and community acquired-pneumonia. Paper presented at: Loyola University Chicago Stritch School of Medicine Annual Forum; 2003 Oct 1; Maywood, IL.
Fine MJ, Stone RA, Lave JR, Hough LJ, Obrosky DS, Mor MK, Kapoor WN. Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial. The American journal of medicine. 2003 Oct 1; 115(5):343-51.
Restrepo MI, Mortensen EM, Anzueto A, Pugh JA. Short-Term Mortality with Fluroquinolone Monotherapy versus Combination Therapy in Severe Community-acquired Pneumonia: A Systematic Review. Paper presented at: Infectious Diseases Society of America Annual Meeting; 2003 Sep 1; San Diego, CA.
Weaver FM, Goldstein B, Legro M. Increasing influenza and pneumococcal pneumonia vaccinations in VA SCI&D. Paper presented at: American Paraplegia Society Annual Meeting; 2003 Sep 1; Las Vegas, NV.
Weaver FM, Goldstein B, Legro M. National Vaccine Project: Increasing Influenza and Pneumococcal Pneumonia Vaccinations in VA SCI. Paper presented at: American Paraplegia Society Annual Meeting; 2003 Sep 1; Las Vegas, NV.
Metlay JP, Kinman JL. Failure to validate pneumococcal pneumonia diagnoses in the general practice research database. Paper presented at: Pharmacoepidemiology and Therapeutic Risk Management Annual International Conference; 2003 Aug 23; Philadelphia, PA.
Aujesky D, Fine MJ. What are the predictors of short-term mortality in patients with community-acquired pneumonia. [Editorial]. The Journal of Respiratory Diseases. 2003 Jun 1; 24:190-192.
Restrepo MI, Mortensen EM, Velez JA, Pugh JA, Anzueto A. Outcomes and Presentation of Extremely Elderly Patients with Community-Acquired Pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2003 May 16; Seattle, WA.
Restrepo MI, Mortensen EM, Velez JA, Pugh JA, Anzueto A. Presentations and Outcomes in Hispanics with Community-Acquired Pneumonia (CAP). Paper presented at: American Thoracic Society Annual International Conference; 2003 May 16; Seattle, WA.
Aujesky D, Auble TE, Yealy DM, Obrosky DS, Stone RA, Fine MJ. Predicting mortality in patients with community-acquired pneumonia: a comparison of 3 prognostic models. Paper presented at: Society of General Internal Medicine Annual Meeting; 2003 May 1; Vancouver, Canada.
Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Guideline-Concordant Antibiotic Therapy and Mortality for Patients with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2003 Apr 1; Vancouver, Canada.
Parada JP. HIV/AIDS-Related Pneumocystis carinii Pneumonia, Medicaid, Bronchoscopy, & Survival. Paper presented at: VA Hines VAMC Research Annual Seminar; 2003 Apr 1; Hines, IL.
Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Annals of internal medicine. 2003 Mar 18; 138(6):494-501.
Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Guideline Concordant Antimicrobial Therapy and Mortality in Community-Acquired Pneumonia. Paper presented at: VA HSR&D National Meeting; 2003 Feb 13; Washington, DC.
Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Annals of internal medicine. 2003 Jan 21; 138(2):109-18.
Metlay JP. Streptococcus pneumoniae: emerging resistance and NCCLS breakpoints. Paper presented at: American Society for Microbiology / National Laboratory Training Network / Eastern Pennsylvania Branch Annual Meeting; 2002 Nov 14; Philadelphia, PA.
Restrepo MI, Adams S, Jorgensen JH, Pugh JA, Anzueto A, Mortensen EM. Processes of Care (POC) in COPD Patients with Community-Acquired Pneumonia (CAP). Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2002 Nov 1; San Diego, CA.
Restrepo MI, Mortensen EM, Jorgensen JH, Pugh JA, Anzueto A. Processes of care (POC) in COPD patients with severe community-acquired pneumonia (SCAP). Paper presented at: Infectious Diseases Society of America Annual Meeting; 2002 Oct 1; Chicago, IL.
Hutt E, Frederickson E, Ecord M, Kramer AM. Processes of care predict survival following nursing home-acquired pneumonia. Journal of clinical outcomes management : JCOM. 2002 Sep 1; 9(5):249-256.
Mortensen EM, Cornell JE, Pederson T, Whittle J. Racial Variations in Processes of Care for Patients with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 May 1; Atlanta, GA.
Fine JM, Fine MJ, Galusha D, Petrillo M, Meehan TP. Patient and hospital characteristics associated with recommended processes of care for elderly patients hospitalized with pneumonia: results from the Medicare quality indicator system pneumonia module. Archives of internal medicine. 2002 Apr 8; 162(7):827-33.
Lautenbach E, Fishman NO, Metlay JP, Bilker WB, Edelstein PH, Strom BL. Fluoroquinolone resistance is independently associated with increased mortality in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Paper presented at: Society for Healthcare Epidemiology of America Scientific Annual Meeting; 2002 Apr 1; Salt Lake City, UT.
Metlay JP. Update on community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes. Current opinion in infectious diseases. 2002 Apr 1; 15(2):163-7.
Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Underperformance of Processes of Care for Veterans Hospitalized with Community-Acquired Pneumonia. Paper presented at: VA HSR&D National Meeting; 2002 Feb 15; Washington, DC.
Fowler RA, Pearl RG, Gould MK. Clinical guidelines for the treatment of ventilator-associated pneumonia. Critical care medicine. 2002 Jan 1; 30(1):266.
Restrepo MI, Jorgensen JH, Mortensen EM, Anzueto A. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy. Current opinion in infectious diseases. 2001 Dec 1; 14(6):703-9.
Yealy DM, Auble TE, Fine MJ. Adult community-acquired pneumonia. In: Frank LR, Jobe KA, editors. Admission & Discharge. Philadelphia, PA: Hanley & Belfus; 2001.
Arozullah AM, Khuri SF, Henderson WG, Daley J. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Annals of internal medicine. 2001 Nov 20; 135(10):847-57.
Rhew DC, Goetz MB, Shekelle PG. Evaluating quality indicators for patients with community-acquired pneumonia. Joint Commission Journal on Quality Improvement. 2001 Nov 1; 27(11):575-90.
Fowler R, Flavin K, Weinacker A, Barr J, Gould MK. Choice of initial empiric antibiotic therapy influences in-hospital survival for patients with ventilator-associated pneumonia. Critical care medicine. 2001 Oct 1; 29:A106.
Arozullah AM, Henderson WG, Khuri S. Predictors of failure to rescue from postoperative pneumonia in patients undergoing major noncardiac surgery. Paper presented at: VA HSR&D National Meeting; 2001 Sep 1; Washington, DC.
Arozullah AM, Henderson WG, Khuri S. Predictors of inpatient mortality among HIV patients with community-acquired pneumonia. Paper presented at: VA HSR&D National Meeting; 2001 Sep 1; Washington, DC.
Halm EA, Switzer GE, Mittman BS, Walsh MB, Chang CC, Fine MJ. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? Journal of general internal medicine. 2001 Sep 1; 16(9):599-605.
Yealy DM, Fine MJ. Community-acquired pneumonia: epidemiology, risk stratification and the decision to admit. In: Rose BD, editor. UpToDate. Wellesley; 2001.
Baine WB, Yu W, Summe JP. Epidemiologic trends in the hospitalization of elderly Medicare patients for pneumonia, 1991-1998. American journal of public health. 2001 Jul 1; 91(7):1121-3.
Collard HR, Saint S. Prevention of ventilator-associated pneumonia. San Francisco, CA: University of California at San Francisco -Stanford University Evidence-based Practice Center; 2001 Jul 1. 185-198 p. Report No.: 01-E058.
Arozullah AM, Henderson W, Khuri S. Predictors of Failure to Rescue from Postoperative Pneumonia in Patients Undergoing Major Noncardiac Surgery. Paper presented at: Society of General Internal Medicine Annual Meeting; 2001 May 1; San Diego, CA.
Arozullah AM, Yarnold PR, Deloriaknoll M. Predictors of Inpatient Mortality Among HIV Patients with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2001 May 1; San Diego, CA.
Mortensen EM, Kapoor WN, Chang J, Fine MJ. Predictors of long-term mortality for patients with community-acquired pneumonia. Presented at: Society of General Internal Medicine Annual Meeting; 2001 Apr 1; San Diego, CA.
Mortensen EM, Obrosky DS, Coley C, =et al. Predictors of pneumonia-related and non-pneumonia-related mortality in community-acquired pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2001 Apr 1; San Diego, CA.
Natarajan S, Rakes K. Diagnosis and Management of Pneumonia. In: Mainous AG, Pomeroy C, editors. Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic rRsistance. Totowa, NJ: Humana Press; 2001. 143-156 p.
Chenoweth CE, Saint S, Martinez F, Lynch JP, Fendrick AM. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. Mayo Clinic proceedings. Mayo Clinic. 2000 Nov 1; 75(11):1161-8.
Halm EA, Mittman BS, Walsh MB, Switzer GE, Chang CH, Fine MJ. The Antibiotic conversion decision in patients hospitalized with pneumonia: Do generalists and specialists think alike? Paper presented at: Society of General Internal Medicine Annual Meeting; 1999 Apr 1; San Francisco, CA.
Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum. 1999 Apr 1; 42(4):780-9.
Bennett CL, Ilraith T. Corticosteroid Utilization and Outcomes in HIV Associated Pneumocystis Carinii Pneumonia: Three-fold Higher Mortality Among Severely Ill Patients when Corticosteroids given by CEC Guidelines. Paper presented at: VA HSR&D National Meeting; 1999 Feb 25; Washington, DC.